Pelago

Pelago validated demand through concrete behavioral signals rather than surveys alone. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Their early users demonstrated genuine commitment by completing multi-week treatment modules, with retention rates exceeding 60%—substantially higher than traditional substance use programs. The company measured authentic interest by tracking engagement metrics: daily app logins, module completion rates, and users returning after their first session. Early traction came through employer partnerships, where companies saw measurable reductions in absenteeism and healthcare costs within three months of implementation. The strongest validation emerged when users voluntarily referred colleagues and family members, creating organic growth without paid acquisition. Employers renewed contracts at 85% rates, proving they perceived real ROI. Pelago's shift from consumer-focused (Quit Genius) to employer-sponsored model reflected this demand signal—companies were willing to pay premium rates for a solution addressing their workforce's substance use challenges. This willingness to pay, combined with sustained usage patterns and measurable health outcomes, proved demand extended far beyond initial interest statements.